NASDAQ:BNGO
Bionano Genomics, Inc.
- Stock
Last Close
1.11
17/05 20:00
Market Cap
47.39M
Beta: 2.26
Volume Today
865.05K
Avg: 7.20M
PE Ratio
−0.17
PFCF: −0.32
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.75M - | 1.38M 20.88% | 2.26M 63.35% | 3.38M 49.80% | 7.85M 132.31% | 21.07M 168.41% | 26.33M 24.92% | ||
average payables | 1.55M - | 1.83M 18.07% | 2.03M 10.84% | 2.81M 38.95% | 6.31M 124.30% | 11.12M 76.07% | 11.46M 3.09% | ||
average receivables | 2.60M - | 3.93M 51.32% | 5.42M 37.90% | 4.55M 16.03% | 3.85M 15.37% | 5.98M 55.09% | 8.17M 36.68% | ||
book value per share | -52.15 - | -185.95 256.60% | 10.08 105.42% | 0.11 98.95% | 0.34 219.17% | 1.22 261.94% | 0.86 29.20% | 2.82 226.52% | |
capex per share | -2.58 - | -3.77 45.93% | -0.33 91.25% | -0.00 99.46% | -0.01 - | -0.01 116.45% | -0.05 333.70% | ||
capex to depreciation | -1.21 - | -0.68 44.10% | -0.25 62.88% | -0.05 78.45% | -0.43 - | -0.34 22.54% | -0.12 63.78% | ||
capex to operating cash flow | 0.06 - | 0.05 14.90% | 0.02 65.98% | 0.00 87.57% | 0.02 - | 0.03 30.33% | 0.01 48.94% | ||
capex to revenue | -0.20 - | -0.11 46.11% | -0.03 74.19% | -0.01 78.19% | -0.08 - | -0.12 46.27% | -0.05 60.58% | ||
cash per share | 10.04 - | 3.78 62.33% | 16.43 334.33% | 0.51 96.93% | 0.37 26.98% | 0.91 145.51% | 0.39 56.78% | 0.53 34.29% | |
days of inventory on hand | 183.32 - | 102.51 44.08% | 44.77 56.33% | 185.71 314.79% | 211.20 13.73% | 320.50 51.75% | 496.99 55.07% | 409.29 17.65% | |
days payables outstanding | 80.81 - | 139.39 72.48% | 56.64 59.37% | 145.56 157.01% | 186.61 28.20% | 250.87 34.43% | 209.31 16.57% | 185.66 11.30% | |
days sales outstanding | 99.22 - | 128.73 29.74% | 137.30 6.66% | 228.23 66.23% | 119.12 47.81% | 100.16 15.92% | 92.19 7.96% | 94.18 2.16% | |
debt to assets | 0.45 - | 0.66 47.88% | 0.36 45.12% | 0.66 82.07% | 0.27 59.26% | 0.03 89.50% | 0.04 33.78% | 0.37 876.14% | |
debt to equity | -0.24 - | -0.13 44.94% | 0.89 764.77% | 5.54 522.07% | 0.47 91.60% | 0.03 93.18% | 0.05 47.46% | 0.83 1,665.25% | |
dividend yield | |||||||||
earnings yield | -0.59 - | -1.41 139.91% | -0.35 75.04% | -0.07 80.00% | -0.01 81.75% | -0.01 31.68% | -0.03 258.78% | -3.60 11,370.78% | |
enterprise value | 33.53M - | 22.32M 33.44% | 45.20M 102.49% | 427.71M 846.37% | 3.19B 645.55% | 8.26B 159.09% | 4.23B 48.81% | 126.01M 97.02% | |
enterprise value over ebitda | -1.66 - | -1.04 36.99% | -2.14 105.45% | -16.53 671.40% | -82.72 400.40% | -107.40 29.85% | -32.43 69.81% | -0.59 98.19% | |
ev to operating cash flow | -1.43 - | -1.07 24.88% | -2.27 111.37% | -14.48 539.16% | -83.23 474.61% | -114.87 38.01% | -33.88 70.50% | -1.01 97.03% | |
ev to sales | 4.94 - | 2.35 52.43% | 3.77 60.38% | 42.22 1,021.20% | 375.02 788.16% | 459.48 22.52% | 152.11 66.89% | 3.49 97.71% | |
free cash flow per share | -47.53 - | -80.84 70.08% | -20.16 75.06% | -0.86 95.72% | -0.37 57.43% | -0.27 27.86% | -0.44 67.08% | -3.72 738.65% | |
free cash flow yield | -0.77 - | -1.31 70.08% | -0.38 70.72% | -0.07 81.91% | -0.01 82.86% | -0.01 25.68% | -0.03 242.16% | -1.97 6,378.42% | |
graham net net | -66.02 - | -207.29 213.96% | 5.75 102.77% | -0.08 101.45% | 0.16 293.61% | 0.80 393.81% | 0.26 67.35% | -2.40 1,021.57% | |
graham number | 205.68 - | 601.61 192.49% | 64.60 89.26% | 1.44 97.78% | 1.73 20.28% | 2.68 54.94% | 2.98 11.37% | 20.77 596.32% | |
income quality | 1.25 - | 0.89 28.53% | 1.08 21.02% | 0.99 8.15% | 0.93 5.89% | 0.99 6.53% | 0.94 5.20% | 0.54 42.80% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.14 Infinity% | 0.22 53.87% | 0.39 74.98% | 0.16 58.86% | |
interest coverage | -45.03 - | -39.29 12.75% | -14.78 62.38% | -11.32 23.44% | -15.30 35.23% | -83.17 443.44% | -441.94 431.35% | 42.05 109.51% | |
interest debt per share | 13.59 - | 27.10 99.46% | 10.35 61.80% | 0.65 93.71% | 0.18 72.23% | 0.04 76.77% | 0.04 1.47% | 2.18 5,158.08% | |
inventory turnover | 1.99 - | 3.56 78.82% | 8.15 128.97% | 1.97 75.89% | 1.73 12.07% | 1.14 34.10% | 0.73 35.51% | 0.89 21.43% | |
invested capital | -0.24 - | -0.13 44.94% | 0.89 764.77% | 5.54 522.07% | 0.47 91.60% | 0.03 93.18% | 0.05 47.46% | 0.83 1,665.25% | |
market cap | 32.15M - | 16.61M 48.33% | 52.69M 217.18% | 425.00M 706.63% | 3.21B 655.51% | 8.28B 157.74% | 4.22B 48.98% | 64.54M 98.47% | |
net current asset value | -31.31M - | -53.23M 70.01% | 8.36M 115.70% | 1.62M 80.64% | 21.42M 1,223.72% | 232.43M 985.03% | 99.19M 57.32% | 21.87M 77.95% | |
net debt to ebitda | -0.07 - | -0.27 290.52% | 0.36 233.20% | -0.10 129.49% | 0.57 647.63% | 0.18 68.57% | -0.05 127.96% | -0.29 466.23% | |
net income per share | -36.06 - | -86.50 139.91% | -18.40 78.74% | -0.87 95.27% | -0.39 54.67% | -0.26 33.68% | -0.46 75.19% | -6.81 1,384.92% | |
operating cash flow per share | -44.95 - | -77.07 71.47% | -19.83 74.27% | -0.86 95.66% | -0.37 57.34% | -0.26 29.29% | -0.43 66.07% | -3.67 749.36% | |
payables turnover | 4.52 - | 2.62 42.02% | 6.44 146.11% | 2.51 61.09% | 1.96 22.00% | 1.45 25.61% | 1.74 19.86% | 1.97 12.74% | |
receivables turnover | 3.68 - | 2.84 22.92% | 2.66 6.25% | 1.60 39.84% | 3.06 91.60% | 3.64 18.94% | 3.96 8.64% | 3.88 2.12% | |
research and ddevelopement to revenue | 1.68 - | 1.26 24.93% | 0.79 37.45% | 0.90 13.44% | 1.21 34.55% | 1.25 3.67% | 1.76 41.08% | 1.50 15.20% | |
return on tangible assets | -1.27 - | -2.30 80.69% | -0.75 67.62% | -0.99 32.44% | -0.79 19.60% | -0.25 68.98% | -0.70 184.74% | -1.29 83.74% | |
revenue per share | 12.99 - | 35.19 170.81% | 11.94 66.08% | 0.30 97.52% | 0.08 72.40% | 0.06 20.35% | 0.10 47.97% | 1.06 1,000.14% | |
roe | 0.69 - | 0.47 32.72% | -1.82 492.22% | -8.26 352.51% | -1.17 85.80% | -0.21 81.68% | -0.53 147.44% | -2.42 354.77% | |
roic | 1.03 - | 0.53 47.98% | -1.07 299.55% | -1.10 2.76% | -0.75 31.50% | -0.20 73.44% | -0.49 145.75% | -1.16 137.23% | |
sales general and administrative to revenue | 1.91 - | 1.48 22.30% | 1.18 20.00% | ||||||
shareholders equity per share | -52.15 - | -185.95 256.60% | 10.08 105.42% | 0.11 98.95% | 0.34 219.17% | 1.22 261.94% | 0.86 29.20% | 2.82 226.52% | |
stock based compensation to revenue | 0.02 - | 0.04 109.42% | 0.11 170.89% | 0.13 21.79% | 0.18 37.54% | 0.54 195.74% | 0.81 49.17% | 0.42 47.88% | |
tangible asset value | -27.26M - | -50.23M 84.26% | 10.14M 120.18% | 3.57M 64.80% | 26.43M 640.90% | 254.12M 861.29% | 130.97M 48.46% | 62.18M 52.52% | |
tangible book value per share | -52.15 - | -185.95 256.60% | 10.08 105.42% | 0.10 98.97% | 0.25 143.59% | 0.92 262.07% | 0.45 50.68% | 1.82 302.10% | |
working capital | 1.37M - | -9.51M 793.45% | 18.50M 294.50% | 1.95M 89.44% | 37.85M 1,837.45% | 250.57M 562.10% | 121.41M 51.55% | 40.09M 66.98% |
All numbers in USD (except ratios and percentages)